Upcoming Pharmaceutical Conferences and Events

 

Other Events

ExxPharma has published an article titled “Comparative Assessment of Spray Drying and Hot Melt Extrusion as Manufacturing Process for Amorphous Solid Dispersion” in American Pharmaceutical Review, September/October 2019:

https://www.americanpharmaceuticalreview.com/Featured-Articles/518491-Comparative-Assessment-of-Spray-Drying-and-Hot-Melt-Extrusion-as-Manufacturing-Processes-for-Amorphous-Solid-Dispersions/?catid=6262

 

ExxPharma participated in a “Drug Delivery Round Table” that was published in American Pharmaceutical Review, September/October 2018:

https://www.americanpharmaceuticalreview.com/Featured-Articles/355224-Drug-Delivery-Roundtable/

 

ExxPharma has filed a patent application with USPTO titled “Novel Bioavailability Enhancement Composition” on July 11, 2018

ExxPharma was granted a patent by the USPTO titled “Tamper-resistant Dosage Form Composition and Process of Making the Same” on July 3, 2018

ExxPharma presented a topic titled “Hot Melt Extrusion Challenges and Solutions” at CPHI North America that was held in Philadelphia, PA, on April 24-26, 2018

ExxPharma has published an article titled “Novel Abuse Deterrent Formulations” in American Pharmaceutical Review, November/December 2017:

https://www.americanpharmaceuticalreview.com/Featured-Articles/345660-Novel-Abuse-Deterrent-Formulations/

ExxPharma participated in a “Drug Delivery Round Table” that was published in American Pharmaceutical Review, September/October 2017:

https://www.americanpharmaceuticalreview.com/Featured-Articles/343841-Drug-Delivery-Roundtable/

 

ExxPharma was granted a patent by the USPTO titled “Tamper-resistant Pharmaceutical Dosage Forms” on September 26, 2017

 

​ExxPharma has published an article titled “The Origin of Hot Melt Extrusion” in American Pharmaceutical Review, July/August 2017:

https://www.americanpharmaceuticalreview.com/Featured-Articles/341249-The-Origins-of-HME-as-a-Solubility-Enhancement-Manufacturing-Technology/

 

ExxPharma was granted a patent by the USPTO titled “Process for Enhancing the Solubility of Poorly Soluble Drugs” on October 27, 2009

 

ExxPharma was granted a patent by the USPTO titled “Continuous melt Spheronization apparatus and process for the production of pharmaceutical pellets” on August 10, 2010

© 2019 ExxPharma Therapeutics LLC                                                  540 Speedwell Avenue       Morris Plains, NJ       www.exxpharma.com       908.231.1819